24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Atox Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:56
Being polite to ChatGPT? It turns out it costs OpenAI millions
16:30
A $35 million VC fund was born at a Gaza war crossing
14:48
Cyvore emerges from stealth to secure digital workspaces
14:42
Romance, lies, and ChatGPT: The scandal shaking Tel Aviv’s startup scene
More stories
Buzz
Most popular
Daily
Weekly
1
“I don’t want to be the richest man in the cemetery” — Morris Kahn on giving it all away at 95
2
Layoffs loom as Intel’s new CEO moves to fix slow decision-making and chip production
3
From startup exits to psychedelic therapy: Eyal Gura’s new mission
4
"Trump’s behavior is destructive. Americans elected an infantile narcissist, and he is causing enormous harm"
5
The million-dollar draft: How Israeli players are breaking into the NBA—and cashing in
More news
Atox Bio
2 stories about Atox Bio
CTech’s Daily Israeli Tech News Roundup
04.12.17
|
CTech
Bank of China partners with Israeli bank to finance Israeli companies in China. Medinol receives FDA approval for the drug-eluting stent. Israel plans solar energy push
Adams Street Partners Backs Critical Care Treatment Startup Atox Bio
04.12.17
|
Lilach Baumer
The company's leading product is currently being tested in clinical trials for the treatment of flesh-eating bacteria and kidney failure
